LJDClass II
Assay, B Lymphocyte Marker
21 CFR 864.5220 / Hematology
LJD is the FDA product code for Assay, B Lymphocyte Marker, a class II device type, regulated under 21 CFR 864.5220. As of , FDA records hold one 510(k) clearance under this code, the most recent dated , and no recalls.
Classification record
- Product code
- LJD
- Device name
- Assay, B Lymphocyte Marker
- Regulation
- 21 CFR 864.5220
- Device class
- Class II
- Review panel
- Hematology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 1
- Ingested recalls
- 0
Clearances, product code LJD
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1986 | 1 |
Applicants with the most clearances
Product code LJD| Applicant | Clearances |
|---|---|
| BD Becton Dickinson Vacutainer Systems Preanalytic | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
